NCT06953076View on ClinicalTrials.gov

Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

RecruitingOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

May 2, 2026

Study Completion Date

May 2, 2027

Conditions
Uterine BleedingUterine LeiomyomasUterine HemorrhageUterine Neoplasms
Interventions
DRUG

Relugolix/estradiol/norethisterone acetate

Oral therapy administered to patients with symptomatic uterine fibroids presenting with abnormal uterine bleeding

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC GINECOLOGIA ONCOLOGICA, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER